Methamphetamine Rehab Placement in Los Angeles
Methamphetamine-related overdose deaths exceeded fentanyl-related deaths in LA County for the first time in years in 2024 — even as both declined (LA County Public Health).
Why stimulant treatment is clinically different
Methamphetamine use disorder has treatment characteristics that differ from opioid or alcohol work. Physical withdrawal is less dramatic but mood crash, anhedonia, and sleep disturbance can persist for weeks. Meth-induced psychosis — paranoia, hallucinations, disorganized thinking — is common with heavy use and requires careful psychiatric stabilization. There are no FDA-approved medications for meth use disorder, so treatment is behavioral: contingency management, CBT, matrix model therapy, and structured behavioral interventions.
What to look for in a meth-capable program
Programs in the referral network that handle meth well typically offer longer stabilization windows (not rushing into the therapy-heavy phase before mood and sleep have regulated), strong psychiatric presence for psychosis screening, contingency management integration, and realistic expectations about the extended recovery curve for stimulant use disorder.
Does insurance cover meth rehab?
Yes. Under SB 855, medically necessary stimulant use disorder treatment is covered on the same terms as other substance use disorder treatment. Placement advisors verify benefits at no cost.
FAQ
Common questions
Why are there no medications for meth?
Research is ongoing — extended-release naltrexone plus bupropion has shown modest effect in trials — but no medication currently has FDA approval for methamphetamine use disorder. Treatment is behavioral.
What about methamphetamine-induced psychosis?
Programs with strong psychiatric capability can manage meth-induced psychosis, which typically resolves with abstinence and sometimes short-term antipsychotic medication. Advisors route to these programs when psychosis is part of the presentation.